BRCA MUTATION
Clinical trials for BRCA MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRCA MUTATION trials appear
Sign up with your email to follow new studies for BRCA MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study is testing an experimental drug called ETX-19477 in people with advanced solid tumors (like breast, ovarian, or prostate cancer) that have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors or slow their…
Matched conditions: BRCA MUTATION
Phase: PHASE1, PHASE2 • Sponsor: 858 Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 07:23 UTC
-
New pill combo targets hard-to-treat inherited cancers
Disease control Recruiting nowThis early-stage study tests two oral drugs (olaparib and ASTX727) together in adults with advanced solid tumors that have specific gene mutations (BRCA1, BRCA2, PALB2, ATM, or CHEK2). The main goals are to find the safest dose and to see if the combination shrinks tumors. About …
Matched conditions: BRCA MUTATION
Phase: PHASE1 • Sponsor: Pamela Munster • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
AI reads ovarian ultrasound to spot hidden cancer genes
Knowledge-focused Recruiting nowThis study aims to develop and test a computer model that can predict whether a woman carries a harmful BRCA1 or BRCA2 gene mutation just by looking at ultrasound images of her healthy ovaries. Researchers will collect images from over 6,400 women across multiple hospitals and us…
Matched conditions: BRCA MUTATION
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 01, 2026 07:24 UTC